- Kalera Public Limited Company (NASDAQ:KAL) has entered into a securities purchase agreement with a single institutional investor.
- The company will receive about $10.0 million through the private placement of 2.5 million shares and warrants.
- Each share is being sold together with accompanying warrants at a combined effective purchase price of $4.00.
- The closing of the private placement is expected to occur on July 11, 2022.
- Maxim Group LLC is acting as the sole placement agent for the offering.
- Price Action: KAL shares are trading higher by 8.16% at $4.77 on the last check Thursday.
Arthritis Patients – Cigna’s Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of $3,500 yearly.
